CERS
Cerus Corporation Healthcare - Medical Devices Investor Relations →
Cerus Corporation (CERS) closed at $2.70 as of 2026-06-19, trading 26.6% above its 200-week moving average of $2.13. The stock moved further from the line this week, up from 19.5% last week. The 14-week RSI sits at 67, indicating neutral momentum.
Trading volume is running at 1.2x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.97 ratio) is neutral — neither side is clearly dominating.
Over the past 1485 weeks of data, CERS has crossed below its 200-week moving average 27 times. On average, these episodes lasted 29 weeks. Historically, investors who bought CERS at the start of these episodes saw an average one-year return of +12.9%.
With a market cap of $541 million, CERS is a small-cap stock. The company generates a free cash flow yield of 0.4%. Return on equity stands at -15.4%. The stock trades at 8.0x book value.
Share count has increased 8.2% over three years, indicating dilution.
Over the past 28.5 years, a hypothetical investment of $100 in CERS would have grown to $16, compared to $1241 for the S&P 500. CERS has returned -6.3% annualized vs 9.2% for the index, underperforming the broader market over this period.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: CERS vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After CERS Crosses Below the Line?
Across 27 historical episodes, buying CERS when it crossed below its 200-week moving average produced an average return of +12.6% after 12 months (median +9.0%), compared to +10.2% for the S&P 500 over the same periods. 60% of those episodes were profitable after one year. After 24 months, the average return was +50.0% vs +22.9% for the index.
Each line shows $100 invested at the moment CERS crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Bean Score Experimental
The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. CERS currently has negative free cash flow, so price-based dislocation levels are not available. The score still tracks yield deviation from baseline.
Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end
Signal Accuracy Collecting Data
The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"
Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.
Dislocation Scores Experimental
Each score measures deviation from CERS's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.
Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.
Historical Touches
CERS has crossed below its 200-week MA 27 times with an average 1-year return of +12.9% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Apr 1998 | Jul 1998 | 13 | 19.3% | +15.8% | -82.0% |
| Aug 1998 | Oct 1998 | 8 | 22.0% | +82.8% | -81.8% |
| Nov 1998 | Nov 1998 | 1 | 1.3% | +95.6% | -82.6% |
| Nov 1998 | Dec 1998 | 1 | 3.8% | +90.9% | -82.1% |
| Apr 1999 | May 1999 | 2 | 4.7% | +128.6% | -83.3% |
| Jun 2002 | Jan 2006 | 188 | 93.5% | -74.0% | -92.5% |
| Apr 2006 | May 2006 | 7 | 12.4% | -7.5% | -65.8% |
| Jul 2006 | Oct 2006 | 12 | 18.4% | +3.4% | -58.6% |
| Jan 2007 | Feb 2007 | 6 | 6.6% | +17.4% | -49.9% |
| Feb 2008 | Mar 2008 | 7 | 26.3% | -86.8% | -55.0% |
| Apr 2008 | Oct 2011 | 184 | 90.1% | -82.1% | -55.7% |
| Nov 2011 | Nov 2011 | 1 | 0.4% | +13.7% | -2.5% |
| Jul 2014 | Sep 2014 | 8 | 6.2% | +46.4% | -30.4% |
| Sep 2014 | Oct 2014 | 3 | 7.3% | +33.6% | -29.1% |
| Mar 2015 | Apr 2015 | 6 | 6.7% | +37.1% | -34.5% |
| Oct 2016 | Nov 2016 | 4 | 7.5% | -39.8% | -47.8% |
| Nov 2016 | Mar 2018 | 66 | 57.6% | -21.9% | -45.8% |
| Dec 2018 | Dec 2018 | 2 | 0.8% | -16.6% | -45.9% |
| May 2019 | Jun 2019 | 4 | 11.6% | +32.6% | -42.4% |
| Sep 2019 | Sep 2019 | 1 | 2.5% | +15.0% | -46.5% |
| Sep 2019 | Feb 2020 | 21 | 21.7% | +25.1% | -44.4% |
| Mar 2020 | Apr 2020 | 4 | 36.7% | +55.5% | -34.3% |
| May 2021 | Jun 2021 | 1 | 3.0% | -6.4% | -49.5% |
| Jul 2021 | Aug 2021 | 4 | 12.8% | +9.9% | -48.8% |
| Jan 2022 | Jan 2026 | 209 | 74.4% | -46.2% | -53.8% |
| Jan 2026 | Feb 2026 | 3 | 8.6% | N/A | +15.9% |
| Mar 2026 | Apr 2026 | 8 | 27.7% | N/A | +39.9% |
| Average | 29 | — | +12.9% | — |
Frequently Asked Questions
Is CERS below its 200-week moving average?
No. Cerus Corporation (CERS) is currently 26.6% above its 200-week moving average of $2.13. It would need to fall to $2.13 to cross below the line.
What is CERS's 200-week moving average price?
Cerus Corporation's 200-week moving average is $2.13 as of 2026-06-19. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when CERS drops below its 200-week moving average?
CERS has crossed below its 200-week moving average 27 times in our data. On average, buying at that moment produced a one-year return of +12.9%. These dips have historically been decent entry points. These episodes lasted 29 weeks on average.
Is CERS a good value right now?
Here's what our data says about CERS as of 2026-06-19: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 67. Free cash flow yield is 0.4%. Return on equity is -15.4%. Price-to-book is 8.0x. This is not a buy or sell recommendation — always do your own research.
How does CERS compare to the S&P 500?
Over the past 28.5 years, $100 invested in CERS would have grown to $16, compared to $1241 for the S&P 500. That's -6.3% annualized vs 9.2% for the index. CERS has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-06-19